Nasdaq
$17.05▼ 0.09%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.12BShares out 65.7M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
22- 3d agoAfter-hours26.10.22 05:55144Ownership#●●●#●●●
Bicara Therapeutics Inc.
Bicara Therapeutics Inc. insider Raben David has filed an SEC Form 144 to report a proposed sale of company securities. This filing serves as a standard notification regarding the planned disposition of shares by an insider.…more
$17.05-0.09%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.7Regular26.10.08 03:57SCHEDULE 13G/AOwnership
Bicara Therapeutics Inc.
T. Rowe Price Investment Management, Inc. has filed a SCHEDULE 13G/A regarding its beneficial ownership in Bicara Therapeutics Inc. This filing serves as an official update on the institutional investor's stake in the company.…more
$17.05-0.09%vs prev closeView filingShare - 9.10After-hours26.09.11 05:234Ownership
Bicara Therapeutics Inc.
Bicara Therapeutics Inc. insider Ryan Cohlhepp filed a Form 4 on September 10, 2026, reporting changes in beneficial ownership of securities as of September 8, 2026. This filing serves as a standard disclosure of executive equity transactions.…more
$17.05-0.09%vs prev closeView filingShare
21 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.5Pre-market26.10.05 21:30#●●●
Bicara Therapeutics Announces Inducement Stock Option Grants
Bicara Therapeutics has granted stock options for 207,150 shares to two new employees as a material inducement for their employment. This is a routine talent acquisition measure under Nasdaq listing rules and is expected to have a neutral impact on the stock.…more
$17.05-0.09%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.3Pre-market26.09.03 21:30
●●●●●●●● ●●●●● ●●●●●●
Bicara Therapeutics has awarded a total of 380,575 stock options to two new employees, including the newly appointed Chief Legal Officer. These grants are part of an inducement plan for talent acquisition and do not have a material impact on the company's valuation.…more
$17.05-0.09%vs prev close - 8.14Pre-market26.08.14 21:30
●●●●●●●● ●●●●● ●●●●●●
Bicara Therapeutics has awarded 285,000 stock options to its new Chief Financial Officer, Jennifer Larson, as an employment inducement. This grant is part of the company's strategy to strengthen its leadership team.…more
$17.05-0.09%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report